<!doctype html>
<html lang="en">
  <head>
    <!-- Title and description ================================================== -->
    
              <meta name="csrf-param" content="authenticity_token">
              <meta name="csrf-token" content="av1lCz8x0X4yB4hfpdiU7xV2xjWhCbAmrHfzPfvgMA7WN/lJF8fULcZGydGcaHAOCHx5ItmnHlTpSozT5J/hnw==">
            
    <title>
      
        Moby | Become a smarter investor in just 5 minutes
      
    </title>
    <meta charset="utf-8" />
    <meta content="IE=edge,chrome=1" http-equiv="X-UA-Compatible">
    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no">
    
      <meta name="description" content="We send you daily investing strategies, stock research, and crypto analysis that&#39;s fun to read and easy to digest. Join today for free and start making smarter investing decisions." />
    

    <!-- Helpers ================================================== -->
    
    
      <link href="https://kajabi-storefronts-production.kajabi-cdn.com/kajabi-storefronts-production/themes/2148837788/settings_images/cT6NmsumSriMG1LbzqFR_Untitled_design_17.png?v=2" rel="shortcut icon" />
    
    <link rel="canonical" href="2151894109.html" />

    <link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.5.0/css/all.css" integrity="sha384-B4dIYHKNBt8Bc12p+WXckhzcICo0wtJAoU8YZTY5qE0Id1GSseTk6S+L3BlXeVIU" crossorigin="anonymous">


    <link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.1.3/css/bootstrap.min.css" integrity="sha384-MCw98/SFnGE8fJT3GXwEOngsV7Zt27NXFoaoApmYm81iuXoPkFOJwJ8ERdknLPMO" crossorigin="anonymous">
    
      <link href="https://fonts.googleapis.com/css?family=Poppins:400,700,400italic,700italic" rel="stylesheet" type="text/css">
    
    <link rel="stylesheet" media="screen" href="https://kajabi-app-assets.kajabi-cdn.com/assets/core-8cc7151051efbc8322c251aae2b556b928bcd0ebfc79f909c1f847eed9932b7f.css" />
    <link rel="stylesheet" media="screen" href="https://kajabi-storefronts-production.kajabi-cdn.com/kajabi-storefronts-production/themes/2148837788/assets/styles.css?1634851986331554" />

    <!-- Header hook ================================================== -->
    <script type="text/javascript">
  var Kajabi = Kajabi || {};
</script>
<script type="text/javascript">
  Kajabi.currentSiteUser = {
    "id" : "2160609026",
    "type" : "Member"
  };
</script>
<script type="text/javascript">
  Kajabi.theme = {
    activeThemeName: "Production Live",
    previewThemeId: null,
    editor: false
  };
</script>
<script>
(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
(i[r].q=i[r].q||[]).push(arguments)
},i[r].l=1*new Date();a=s.createElement(o),
m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
})(window,document,'script','//www.google-analytics.com/analytics.js','ga');

ga('create', 'UA-199580424-1', 'auto', {"userId":2202749271});
ga('send', 'pageview');
</script>
<style type="text/css">
  #editor-overlay {
    display: none;
    border-color: #2E91FC;
    position: absolute;
    background-color: rgba(46,145,252,0.05);
    border-style: dashed;
    border-width: 3px;
    border-radius: 3px;
    pointer-events: none;
    cursor: pointer;
    z-index: 10000000000;
  }
  .editor-overlay-button {
    color: white;
    background: #2E91FC;
    border-radius: 2px;
    font-size: 13px;
    margin-left: -24px;
    margin-top: -12px;
    padding: 3px 10px;
    text-transform:uppercase;
    font-weight:bold;
    letter-spacing:1.5px;

    left: 50%;
    top: 50%;
    position: absolute;
  }
</style>
<script>
!function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function(){n.callMethod?
n.callMethod.apply(n,arguments):n.queue.push(arguments)};if(!f._fbq)f._fbq=n;
n.push=n;n.loaded=!0;n.version='2.0';n.agent='plkajabi';n.queue=[];t=b.createElement(e);t.async=!0;
t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
                                                                      document,'script','https://connect.facebook.net/en_US/fbevents.js');

fbq('init', '664252340905038', {"ct":null,"country":null,"em":"ilya.ek@gmail.com","fn":"Ilya","ln":"Kiselev","pn":null,"zp":null});
fbq('track', "PageView");</script>
<noscript><img height="1" width="1" style="display:none"
src="https://www.facebook.com/tr?id=664252340905038&ev=PageView&noscript=1"
/></noscript>
<!-- Google Tag Manager -->
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-5SBLJRW');</script>
<!-- End Google Tag Manager --><meta name='site_locale' content='en'>
  </head>
  <body class="d-flex flex-fill">

    <div class="main-sidebar col flex-fill">
  <div id="section-mini_dashboard" data-section-id="mini_dashboard">














<div class="mini-dashboard">
  <a href="../../../../premium-investing-research.1.html" class="mini-dashboard-back" kjb-settings-id="sections_mini_dashboard_settings_dashboard">
    <i class="fas fa-chevron-left"></i>
    Dashboard
  </a>
  <h1 class="mini-dashboard-title">Premium Investing Research</h1>
  <div class="media">
    <div class="mr align-self-center">
      <div class="avatar avatar-sm avatar-light avatar-1">
        <img class="avatar-img" src="https://www.gravatar.com/avatar/df42ea502a25d65db01cfd5e62d26643?s=42&d=https://s3.amazonaws.com/kajabi-storefronts-production/static_assets/default_avatar.jpg"/>
      </div>
    </div>
    <div class="media-body">
      <h5 class="mini-dashboard-user">Ilya Kiselev</h5>
      <div class="mini-dashboard-completion" kjb-settings-id="sections_mini_dashboard_settings_complete">1% Complete</div>
    </div>
  </div>
</div>

</div>
  <div id="section-product_outline" data-section-id="product_outline">

<div class="product-outline">
  
    
      <h3 class="product-outline-category"><a href="../../2148695518.html">Investing Strategies</a></h3>
      
      
        
          
            <h3 class="product-outline-subcategory"><a href="../../2148695519.1.html">Information Technology</a></h3>
            
          
        
          
            <h3 class="product-outline-subcategory"><a href="../../2148695520.1.html">Consumer Discretionary</a></h3>
            
          
        
          
            <h3 class="product-outline-subcategory"><a href="../../2148721378.1.html">Industrials</a></h3>
            
          
        
          
            <h3 class="product-outline-subcategory"><a href="../../2148721389.1.html">Financials</a></h3>
            
          
        
          
            <h3 class="product-outline-subcategory"><a href="../../2148721380.1.html">Health Care</a></h3>
            
          
        
          
            <h3 class="product-outline-subcategory"><a href="../../2148721417.1.html">Communication Services</a></h3>
            
          
        
          
            <h3 class="product-outline-subcategory"><a href="../../2148721435.1.html">Energy</a></h3>
            
          
        
          
            <h3 class="product-outline-subcategory"><a href="../../2148721471.html">Real Estate</a></h3>
            
          
        
          
            <h3 class="product-outline-subcategory"><a href="../../2148721438.html">Materials</a></h3>
            
          
        
      
    
  
    
      <h3 class="product-outline-category"><a href="../../2148737584.1.html">Crypto</a></h3>
      
      
    
  
    
      <h3 class="product-outline-category"><a href="../../2148721319.1.html">Market & Industry Analysis</a></h3>
      
      
    
  
    
      <h3 class="product-outline-category"><a href="../../2148721346.1.html">Rankings and Lists</a></h3>
      
      
    
  
    
      <h3 class="product-outline-category"><a href="../../2148721443.1.html">Hedge Fund Holdings</a></h3>
      
      
    
  
    
      <h3 class="product-outline-category"><a href="../../2148721457.1.html">Portfolio Strategy</a></h3>
      
      
    
  
</div>
</div>
</div>
<div class="main-content col flex-fill">
  





<div class="responsive-toggle">
  <div class="media">
    <div class="align-self-center"><i class="responsive-toggle-trigger fas fa-bars"></i></div>
    <div class="align-self-center media-body">
      
        <form action="https://www.moby.co/products/premium-investing-research/search" method="get" role="search">
          <div class="input-group search" kjb-settings-id="show_search">
            <div class="input-group-prepend">
              <div class="input-group-text search-icon"><i class="fa fa-search"></i></div>
            </div>
            <input class="form-control search-input" type="search" name="q" placeholder="Search for something..." kjb-settings-id="search_text">
          </div>
        </form>
      
    </div>
  </div>
</div>

  






  <form action="https://www.moby.co/products/premium-investing-research/search" method="get" role="search">
    <div class="input-group search post-page" kjb-settings-id="show_search">
      <div class="input-group-prepend">
        <div class="input-group-text search-icon"><i class="fa fa-search"></i></div>
      </div>
      <input class="form-control search-input" type="search" name="q" placeholder="Search for something..." kjb-settings-id="search_text">
    </div>
  </form>


  





  <div id="section-post_actions" data-section-id="post_actions">















<div class="post-actions" kjb-settings-id="sections_post_actions_settings_downloads">
  <div class="media align-items-center">
    <div class="post-actions-pagination">
      
        <a href="https://www.moby.co/products/premium-investing-research/categories/2148721346/posts/2151894647">
          <i class="fas fa-angle-left"></i>
        </a>
      
    </div>
    <div class="media-body">
      <div class="post-actions-container">
        <div class="media align-items-center">
          <div class="media-body">
            
            

          </div>
          <div>
            <a href="2151894109.html#" data-favorite-toggle="true" data-favorited="true" data-favorite-token="BAh7CEkiCGdpZAY6BkVUSSIpZ2lkOi8va2FqYWJpLXBvcnRhbHMvUG9zdC8yMTUxODk0MTA5BjsAVEkiDHB1cnBvc2UGOwBUSSIOZmF2b3JpdGVzBjsAVEkiD2V4cGlyZXNfYXQGOwBUSSIdMjAyMS0xMS0yM1QxNjo1NTowMC41MjNaBjsAVA==--8a3af5607039eb8440591223ff78028acd6d1e80" class="post-actions-favorite favorited">
              <i class="far fa-star"></i>
            </a>
          </div>
          <div>
            <a href="2151894109.html#" data-complete-text="Mark As Read" data-incomplete-text="Read" data-post-completion-toggle="false" data-token="eyJ0eXAiOiJKV1QiLCJhbGciOiJIUzI1NiJ9.eyJhY3Rvcl90eXBlIjoiTWVtYmVyIiwiYWN0b3JfaWQiOjIxNjA2MDkwMjYsInByb2R1Y3RfaWQiOjIxNDc2MzM1MzcsInBvc3RfaWQiOjIxNTE4OTQxMDl9.ACQZr9WDOipVMRY-sn-ouXNaq8lH77KdlO5pzOT5Cbo" class="btn post-actions-complete">
              
                Mark As Read
              
            </a>
          </div>
        </div>
      </div>
    </div>
    <div class="post-actions-pagination">
      
        <a href="2151895082.html">
          <i class="fas fa-angle-right"></i>
        </a>
      
    </div>
  </div>
</div>

</div>
  <div class="post-body">
  <div class="main-content-container">
    

    <h1 class="post-body-title">Why These Are Our Top 2 Healthcare Stocks of 2021</h1>
    <div data-mobiledoc="{&quot;version&quot;:&quot;0.3.2&quot;,&quot;atoms&quot;:[],&quot;cards&quot;:[],&quot;markups&quot;:[],&quot;sections&quot;:[[1,&quot;p&quot;,[[0,[],0,&quot;While we don" t="" write="" about="" healthcare="" stocks="" often="" they="" are="" extremely="" important="" to="" watch="" out="" for="" the="" sector="" in="" united="" states="" alone="" represents="" over="" 3="" trillion="" dollars="" and="" makes="" up="" 17="" of="" gdp="" this="" number="" is="" projected="" grow="" 25="" by="" 2030="">
<div>
<p><span style="color: #bacfe7;"><em>Published on September 7, 2021</em></span></p>
<p><span style="color: #332f4f;">While we don't write about healthcare stocks often, they are extremely important to watch out for. The healthcare sector in the United States alone represents over 3 trillion dollars and makes up over 17% of the United States GDP! And this number is projected to grow up to 25% by 2030!</span></p>
</div>
</div>
<blockquote><strong><span style="color: #06cbf8;">What this means is that healthcare is projected to become the biggest market in the United States and therefore the opportunity to invest in its future cannot be ignored.</span></strong></blockquote>
<p><strong><span style="color: #06cbf8;"><span style="color: #332f4f;"></span></span></strong></p>
<div data-mobiledoc="{&quot;version&quot;:&quot;0.3.2&quot;,&quot;atoms&quot;:[[&quot;soft-return&quot;,&quot;&quot;,{}],[&quot;soft-return&quot;,&quot;&quot;,{}]],&quot;cards&quot;:[],&quot;markups&quot;:[[&quot;strong&quot;]],&quot;sections&quot;:[[1,&quot;h2&quot;,[[0,[0],1,&quot;Health Care List Overview:&quot;]]],[1,&quot;p&quot;,[[0,[],0,&quot;While the stocks below are not household names like Apple or Tesla, these companies either are massive or have long term potential for serious growth. &quot;]]],[1,&quot;p&quot;,[[0,[],0,&quot;And if you" re="" not="" sold="" on="" owning="" healthcare="" stocks="" diversification="" is="" a="" key="" sticking="" point="" as="" to="" why="" they="" should="" be="" included="" in="" portfolio="" we="" ve="" preached="" here="" at="" moby="" before="" diversifying="" your="" very="" important="" any="" sell-off="" s="" certain="" sectors="" occur="" you="" can="" hedge="" yourself="" from="" these="" sector="" specific="" sell-offs="" conversely="" if="" were="" appreciate="" and="" diversified="" may="" now="" able="" participate="" rally="" that="" previously="" unable="" 1="" h2="" 0="" top="" 2="" stocks:="" p="" so="" with="" context="" the="" list="" below="" contains="" of="" our="" favorite="" invest="" within="" please="" let="" us="" know="" have="" questions="" note="" also="" consists="" several="" verticals="" such="" but="" limited="" to:="" pharmaceuticals="" biotech="" equipment="" tech="" etc="" schrodinger="" inc="" sdgr="" :="" an="" american="" life="" sciences="" materials="" science="" company="" founded="" 1990="" develops="" software="" for="" computational="" chemistry="" has="" pipeline="" collaborative="" internal="" drug="" discovery="" programs="">
<div>
<h2><span style="color: #332f4f;"><strong>Health Care List Overview:</strong></span></h2>
<p><span style="color: #332f4f;">While the stocks below are not household names like Apple or Tesla, these companies either are massive or have long term potential for serious growth.</span></p>
<p><span style="color: #332f4f;">And if you're not sold on owning healthcare stocks, diversification is a key sticking point as to why they should be included in a portfolio. As we've preached here at Moby before, diversifying your portfolio is very important! Diversification is important should any sell-off's to certain sectors occur, you can "hedge" yourself from these sector specific sell-offs. Conversely if a sector were to appreciate, and you were diversified, you may now be able to participate in a rally that you previously were unable to participate in!</span></p>
<p>&nbsp;</p>
<h2><span style="color: #332f4f;"><strong>Top 2 Healthcare Stocks:</strong></span></h2>
<p><span style="color: #332f4f;"><strong>So with that context, the list below contains 2 of our favorite stocks to invest in within the healthcare sector! </strong>Please let us know if you have any questions! Please note healthcare also consists of several verticals such as but not limited to: Pharmaceuticals, Biotech, Equipment, Tech, etc.</span></p>
<p><span style="color: #332f4f;"><strong>1) Schrodinger Inc (SDGR): </strong>Schrodinger is an American life sciences and materials science company founded in 1990 that develops software for computational chemistry and has a pipeline of collaborative and internal drug discovery programs.</span></p>
</div>
</div>
<div data-mobiledoc="{&quot;version&quot;:&quot;0.3.2&quot;,&quot;atoms&quot;:[],&quot;cards&quot;:[[&quot;hr&quot;,{}],[&quot;hr&quot;,{}]],&quot;markups&quot;:[[&quot;strong&quot;]],&quot;sections&quot;:[[1,&quot;p&quot;,[[0,[],0,&quot;We are initiating an overweight rating on SDGR for two main reasons. This is because:&quot;]]],[3,&quot;ul&quot;,[[[0,[0],1,&quot;Their current stock price is extremely attractive given the stock is down 20% this year. &quot;],[0,[],0,&quot;Even with sales growing, the market cap has contracted leaving the stock undervalued. With what should be strong second half growth, we see the stock reversing course soon.&quot;]],[[0,[0],1,&quot;The reason shares have been trending downwards was largely due to the guidance the company issued back in Q1 of this year. &quot;],[0,[],0,&quot;Since then investors panic sold and the stock price dropped more than it should have. Given how seasonal their contracts are, we believe sales should spike in Q3 &amp; Q4 leading to large outperformance vs what people are expecting.&quot;]]]],[10,0],[1,&quot;p&quot;,[[0,[0],1,&quot;2) Veeva Systems (VEEV): &quot;],[0,[],0,&quot;Veeva Systems Inc. is an American cloud-computing company focused on pharmaceutical and life sciences industry applications. It works with software as a service (SaaS) in the global life-science industry.&quot;]]],[1,&quot;p&quot;,[[0,[],0,&quot;We" v="" written="" about="" veev="" before="" as="" one="" of="" our="" top="" healthcare="" stocks="" but="" new="" analysis="" shows="" the="" following="" should="" be="" a="" strong="" name="" for="" investors="" over="" next="" few="" years="" 3="" ul="" 0="" 1="" revenue="" growth:="" during="" their="" most="" recent="" earnings="" report="" we="" see="" that="" clocked="" in="" at="" 456m="" and="" was="" well="" ahead="" what="" people="" thought="" 451m="" when="" looking="" more="" closely="" caused="" outperformance="" subscription="" drove="" growth="" knowing="" has="" high="" margins="" is="" scalable="" re="" extremely="" excited="" to="" this="" driving="" think="" market="" missed="" therefore="" are="" getting="" now="" 10="" h2="" bonus="" content:="" p="" also="" like="" stock="" biogen="" biib="" they="" ve="" gone="" through="" some="" volatility="" year="" reason="" largely="" due="" drug="" helping="" fight="" alzheimers="" us="" fda="" first="" approved="" s="" treatment="" on="" june="" 7="" 2021="" early="" stage="" alzheimer="" disease="" since="" backlash="" so="" monumental="" because="" it="" therapy="" disorder="" nearly="" two="" decades="" -="" marking="" serious="" success="" against="" growing="" terrible="" diseases="" however="" ruling="" there="" been="" medical="" community="" results="" still="" murky="" blockquote="" waiting="" further="" initiating="" rating="" do="" note="" other="" potential="" drugs="" pipeline="" if="" you="" risk="" taking="" investor="" could="" have="" nice="" upside="" comes="" with="" downside="" proceed="" caution="" not="" appetite="" associated="" time="">
<div>
<p><span style="color: #332f4f;">We are initiating an overweight rating on SDGR for two main reasons. This is because:</span></p>
<ol>
<li><span style="color: #332f4f;"><strong>Their current stock price is extremely attractive given the stock is down 20% this year. </strong>Even with sales growing, the market cap has contracted leaving the stock undervalued. With what should be strong second half growth, we see the stock reversing course soon.</span></li>
<li><span style="color: #332f4f;"><strong>The reason shares have been trending downwards was largely due to the guidance the company issued back in Q1 of this year. </strong>Since then investors panic sold and the stock price dropped more than it should have. Given how seasonal their contracts are, we believe sales should spike in Q3 &amp; Q4 leading to large outperformance vs what people are expecting.</span></li>
</ol>
<p>&nbsp;</p>
<hr />
<p>&nbsp;</p>
<p><span style="color: #332f4f;"><strong>2) Veeva Systems (VEEV): </strong>Veeva Systems Inc. is an American cloud-computing company focused on pharmaceutical and life sciences industry applications. It works with software as a service (SaaS) in the global life-science industry.</span></p>
<p><span style="color: #332f4f;">We'v written about VEEV before as one of our top healthcare stocks but our new analysis shows the following. VEEV should be a strong name for healthcare investors over the next few years.</span></p>
<ul>
<li><span style="color: #332f4f;"><strong>Strong Revenue Growth: </strong>During their most recent earnings report we see that their revenue clocked in at $456M and was well ahead of what people thought ($451M). When looking more closely at what caused the outperformance, we see that their subscription revenue drove most of the growth. Knowing that subscription revenue has high margins and is scalable, we're extremely excited to see this driving the outperformance. We think the market missed this and therefore are getting in now.</span></li>
</ul>
<p>&nbsp;</p>
<hr />
<h2>&nbsp;</h2>
<h2><span style="color: #332f4f;"><strong>BONUS CONTENT:</strong></span></h2>
<p><span style="color: #332f4f;">We also like the stock Biogen (BIIB) but they've gone through some strong volatility this year. The reason for the volatility is largely due to their drug helping fight Alzheimers. The US FDA first approved Biogen's treatment on June 7, 2021 for early stage Alzheimer's disease but since has gone through strong backlash. The reason this was so monumental was because it was the first new therapy approved for the disorder in nearly two decades - marking some serious success against the growing and terrible diseases. However, since the ruling, there has been serious backlash in the medical community and the results are still murky.</span></p>
<blockquote><span style="color: #06cbf8;"><strong>Therefore, we are waiting further before initiating a rating but do note the other strong potential drugs in their pipeline.</strong></span></blockquote>
<p><span style="color: #332f4f;">If you are a strong risk taking investor, this could have some nice upside but also comes with strong downside risk. Proceed with caution.<strong>&nbsp;</strong>We do not have the appetite for the associated risk at this time.</span></p>
</div>
</div>
<p><strong><span style="color: #06cbf8;"><span style="color: #332f4f;">&nbsp;</span><br /></span></strong></p>
    <hr />
  </div>
</div>

  


  <div class="comments">
    <div class="main-content-container">
      
        <form novalidate="novalidate" class="new_comment" id="new_comment" action="https://www.moby.co/posts/2151894109/comments" accept-charset="UTF-8" data-remote="true" method="POST"><input name="utf8" type="hidden" value="âœ“">
          <div class="media">
            <div>
              <img class="comments-img" src="https://www.gravatar.com/avatar/df42ea502a25d65db01cfd5e62d26643?s=42&d=https://s3.amazonaws.com/kajabi-storefronts-production/static_assets/default_avatar.jpg"/>
            </div>
            <div class="media-body">
              <textarea kjb-settings-id="language_comment_placeholder" rows="5" placeholder="Say Something..." name="comment[body]" id="comment_body" class="form-control"></textarea>
              <input kjb-settings-id="language_comment_add" class="btn comments-btn" type="submit" name="commit" data-disable-with="submitting" value="Post Comment">
            </div>
          </div>
        </form>
      
      
    </div>
  </div>


</div>
<div id="section-post_completion" data-section-id="post_completion">
























<div class="post-completion" data-page="/products/premium-investing-research/categories/2148721346/posts/2151895082" data-counter="10" data-auto="false">
  <div class="post-completion-box">
    <div class="avatar avatar-md avatar-grey avatar-1">
      <img class="avatar-img" src="https://www.gravatar.com/avatar/df42ea502a25d65db01cfd5e62d26643?s=42&d=https://s3.amazonaws.com/kajabi-storefronts-production/static_assets/default_avatar.jpg"/>
    </div>
    <div class="post-completion-box-percent" kjb-settings-id="sections_post_completion_settings_complete_text">1% Complete</div>
    <h4 class="post-completion-box-message" kjb-settings-id="sections_post_completion_settings_message_text">Nice Work, Ilya</h4>
    <p class="post-completion-box-post" kjb-settings-id="sections_post_completion_settings_lesson_text">You just completed the lesson:<br />Why These Are Our Top 2 Healthcare Stocks of 2021</p>
    
      <a href="2151895082.html" class="btn post-completion-box-btn" kjb-settings-id="sections_post_completion_settings_next_text">
        Go to Next Lesson
      </a>
    
    <a href="2151894109.html#" class="post-completion-box-cancel" kjb-settings-id="sections_post_completion_settings_cancel_text">Cancel</a>
  </div>
  
</div>


</div>

    <!-- Javascripts ================================================== -->
    <script src="https://kajabi-app-assets.kajabi-cdn.com/assets/core-0664a32a302da74190b5d9deb7357551e8d29b4a22f5c04abbef07d27402c317.js"></script>
    <script charset='ISO-8859-1' src='https://fast.wistia.com/assets/external/E-v1.js'></script>
    <script charset='ISO-8859-1' src='https://fast.wistia.com/labs/crop-fill/plugin.js'></script>
    <script src="https://kajabi-storefronts-production.kajabi-cdn.com/kajabi-storefronts-production/themes/2148837788/assets/scripts.js?1634851986331554"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/popper.js/1.14.3/umd/popper.min.js" integrity="sha384-ZMP7rVo3mIykV+2+9J3UJ46jBk0WLaUAdn689aCwoqbBJiSnjAK/l8WvCWPIPm49" crossorigin="anonymous"></script>
    <script src="https://stackpath.bootstrapcdn.com/bootstrap/4.1.3/js/bootstrap.min.js" integrity="sha384-ChfqqxuZUCnJSK3+MXmPNIyE6ZbWh2IMqE241rYiqJxyMiZ6OW/JmZQ5stwEULTy" crossorigin="anonymous"></script>
  </body>
</html>